drugset / Trial / NCT04505657
Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography
RandomizedParallel-groupSingle-blindPrevention
Summary
our aims to investigate the effectiveness of10% Lidocaine Spray plus oral celecoxib for Pain Control During Hysterosalpingography
Timeline
- Start
- 2020-09-01
- Primary completion
- 2021-06-30
- Completion
- 2021-09-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Celecoxib | Other / unclassified | 200 mg | Oral |
| Subject | Lidocaine | Other / unclassified | 10 % | Other |